Yahoo
NasdaqGM - Delayed Quote USD

Drugs Made In America Acquisition Corp. (DMAAU)

11.15 +0.14 (+1.27%)
At close: November 3 at 4:00:00 PM EST
Chart Range Bar
Loading chart for DMAAU
  • Previous Close 11.01
  • Open 11.15
  • Bid 10.54 x 100
  • Ask 10.13 x 16700
  • Day's Range 11.15 - 11.15
  • 52 Week Range 10.30 - 12.50
  • Volume 203
  • Avg. Volume 77
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

--

Full Time Employees

December 31

Fiscal Year Ends

Shell Companies

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DMAAU
6.29%
S&P 500 (^GSPC)
7.76%

1-Year Return

DMAAU
5.29%
S&P 500 (^GSPC)
9.77%

3-Year Return

DMAAU
11.39%
S&P 500 (^GSPC)
68.96%

5-Year Return

DMAAU
11.39%
S&P 500 (^GSPC)
57.04%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    6.09M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.28k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: